Nifty
:
14644.70
Sensex
:
49792.12
123.55 (0.85%)
393.83 (0.80%)
Nifty
Sensex
:
:
14644.70
49792.12
123.55 (0.85%)
393.83 (0.80%)

Kilitch Drugs (India) Ltd.

Pharmaceuticals & Drugs

Rating :
40/99

BSE: 524500 | NSE: KILITCH

NSE BSE
94.95
19-Jan-2021
  • Open
  • High
  • Low
  • Previous Close
  •  93.45
  •  96.75
  •  93.25
  •  93.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1623
  •  1.54
  •  139.00
  •  61.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 146.19
  • 329.87
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 156.93
  • N/A
  • 1.21

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.63%
  • 0.47%
  • 27.70%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.20%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.60
  • 20.50
  • 1.49

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -25.47
  • -70.26
  • -26.83

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -22.36
  • -
  • -45.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.36
  • 21.54
  • 50.04

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.88
  • 1.23
  • 1.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.50
  • -1.30
  • 14.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
18.07
15.33
17.87%
10.19
10.43
-2.30%
11.62
19.17
-39.38%
15.93
8.42
89.19%
Expenses
15.12
13.62
11.01%
11.30
11.16
1.25%
13.93
16.24
-14.22%
14.41
11.97
20.38%
EBITDA
2.96
1.71
73.10%
-1.11
-0.73
-
-2.30
2.93
-
1.52
-3.55
-
EBIDTM
16.36%
11.16%
-10.92%
-7.01%
-19.83%
15.29%
9.55%
-42.22%
Other Income
0.42
0.59
-28.81%
0.37
1.38
-73.19%
1.47
-0.62
-
0.69
0.33
109.09%
Interest
0.18
0.16
12.50%
0.29
0.15
93.33%
0.23
0.38
-39.47%
0.17
0.00
0
Depreciation
0.50
0.45
11.11%
0.49
0.44
11.36%
0.52
0.55
-5.45%
0.59
0.52
13.46%
PBT
2.71
1.68
61.31%
-1.52
0.06
-
-1.59
1.38
-
1.45
-3.75
-
Tax
0.50
0.35
42.86%
-0.19
0.25
-
-0.34
0.88
-
0.51
1.07
-52.34%
PAT
2.21
1.34
64.93%
-1.33
-0.19
-
-1.25
0.50
-
0.95
-4.82
-
PATM
12.22%
8.72%
-13.08%
-1.85%
-10.72%
2.59%
5.94%
-57.22%
EPS
1.35
0.87
55.17%
-0.86
-0.13
-
-0.81
0.32
-
0.61
-3.12
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Net Sales
55.81
53.32
82.49
51.01
28.65
20.99
19.03
107.96
146.30
142.66
Net Sales Growth
4.61%
-35.36%
61.71%
78.05%
36.49%
10.30%
-82.37%
-26.21%
2.55%
 
Cost Of Goods Sold
31.02
29.09
48.17
26.00
11.25
8.73
7.02
71.19
100.27
98.28
Gross Profit
24.79
24.23
34.32
25.01
17.39
12.25
12.01
36.78
46.03
44.38
GP Margin
44.41%
45.44%
41.61%
49.03%
60.70%
58.36%
63.11%
34.07%
31.46%
31.11%
Total Expenditure
54.76
53.33
76.47
45.71
29.20
25.29
20.79
95.34
124.23
118.99
Power & Fuel Cost
-
1.68
1.48
1.15
1.10
0.97
0.82
6.35
6.56
4.82
% Of Sales
-
3.15%
1.79%
2.25%
3.84%
4.62%
4.31%
5.88%
4.48%
3.38%
Employee Cost
-
5.69
5.28
4.30
3.38
3.47
3.13
6.44
5.62
4.10
% Of Sales
-
10.67%
6.40%
8.43%
11.80%
16.53%
16.45%
5.97%
3.84%
2.87%
Manufacturing Exp.
-
3.55
2.88
2.18
2.73
2.68
1.66
5.98
7.60
7.38
% Of Sales
-
6.66%
3.49%
4.27%
9.53%
12.77%
8.72%
5.54%
5.19%
5.17%
General & Admin Exp.
-
6.32
4.78
3.27
2.80
2.71
2.52
2.04
1.88
1.92
% Of Sales
-
11.85%
5.79%
6.41%
9.77%
12.91%
13.24%
1.89%
1.29%
1.35%
Selling & Distn. Exp.
-
6.20
8.64
5.22
4.71
3.46
2.00
2.02
1.47
1.57
% Of Sales
-
11.63%
10.47%
10.23%
16.44%
16.48%
10.51%
1.87%
1.00%
1.10%
Miscellaneous Exp.
-
0.80
5.24
3.59
3.21
3.27
3.64
1.32
0.83
0.92
% Of Sales
-
1.50%
6.35%
7.04%
11.20%
15.58%
19.13%
1.22%
0.57%
0.64%
EBITDA
1.07
-0.01
6.02
5.30
-0.55
-4.30
-1.76
12.62
22.07
23.67
EBITDA Margin
1.92%
-0.02%
7.30%
10.39%
-1.92%
-20.49%
-9.25%
11.69%
15.09%
16.59%
Other Income
2.95
4.55
5.26
3.27
1.14
2.78
2.72
1.06
0.17
0.48
Interest
0.87
0.94
0.65
0.42
0.16
0.06
0.05
2.96
3.54
4.53
Depreciation
2.10
2.00
2.05
2.04
9.76
10.05
1.85
4.87
5.59
6.07
PBT
1.05
1.61
8.59
6.11
-9.32
-11.63
-0.95
5.84
13.12
13.55
Tax
0.48
0.77
4.76
0.96
-0.43
-0.44
-0.66
21.05
2.63
2.81
Tax Rate
45.71%
47.83%
55.41%
15.71%
4.61%
3.78%
69.47%
21.62%
20.05%
20.74%
PAT
0.58
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.87
10.56
10.74
PAT before Minority Interest
0.45
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.31
10.49
10.74
Minority Interest
-0.13
0.00
0.00
0.00
0.00
0.00
0.00
0.56
0.07
0.00
PAT Margin
1.04%
1.58%
4.64%
10.10%
-31.03%
-53.31%
-1.52%
71.20%
7.22%
7.53%
PAT Growth
118.30%
-78.07%
-25.63%
-
-
-
-
627.94%
-1.68%
 
EPS
0.37
0.54
2.47
3.32
-5.74
-7.22
-0.19
49.59
6.81
6.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Shareholder's Funds
118.25
121.06
112.03
101.20
108.69
119.88
114.55
84.31
75.15
Share Capital
15.43
15.36
13.73
13.23
13.23
13.23
13.23
13.23
13.20
Total Reserves
101.63
104.58
94.56
86.59
94.08
105.27
99.94
69.20
59.88
Non-Current Liabilities
-0.58
-0.62
-1.55
-2.47
-0.95
-0.51
0.82
0.89
38.48
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
42.99
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
Long Term Provisions
0.39
0.41
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
21.97
20.09
14.92
11.69
7.99
6.85
60.47
66.23
21.18
Trade Payables
7.10
4.35
7.72
5.68
3.69
2.39
3.66
10.25
11.83
Other Current Liabilities
1.22
3.89
3.50
3.22
3.35
3.92
1.33
38.00
2.16
Short Term Borrowings
12.61
9.45
0.92
0.69
0.19
0.00
8.77
15.63
0.00
Short Term Provisions
1.04
2.40
2.78
2.11
0.77
0.55
46.71
2.35
7.19
Total Liabilities
141.86
142.63
126.13
110.42
115.73
126.22
176.92
153.00
134.81
Net Block
31.53
32.13
32.96
33.31
42.41
9.38
8.64
41.93
44.26
Gross Block
70.59
69.19
67.97
66.28
65.62
22.55
20.78
74.27
70.99
Accumulated Depreciation
39.06
37.06
35.01
32.97
23.21
13.16
12.14
32.34
26.73
Non Current Assets
86.08
77.75
63.14
61.85
68.43
79.48
9.61
85.48
67.38
Capital Work in Progress
29.60
20.25
3.18
0.66
0.00
0.00
0.00
43.15
22.11
Non Current Investment
24.05
25.02
26.00
27.01
25.82
47.16
0.72
0.22
1.02
Long Term Loans & Adv.
0.36
0.34
0.22
0.08
0.20
22.94
0.25
0.19
0.00
Other Non Current Assets
0.54
0.00
0.79
0.79
0.00
0.00
0.00
0.00
0.00
Current Assets
55.79
64.88
62.98
48.57
47.27
46.72
167.31
67.51
67.08
Current Investments
27.81
28.42
30.29
26.02
23.12
24.67
137.59
0.00
0.00
Inventories
5.56
4.72
2.80
2.60
2.62
2.38
2.30
17.02
12.45
Sundry Debtors
15.86
19.44
20.69
14.61
16.37
12.62
15.03
38.70
47.92
Cash & Bank
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
3.95
Other Current Assets
3.77
0.16
0.36
0.07
2.41
2.07
0.73
2.30
2.76
Short Term Loans & Adv.
3.73
4.21
4.07
2.98
2.38
2.00
0.22
1.30
2.71
Net Current Assets
33.81
44.78
48.07
36.87
39.28
39.87
106.84
1.28
45.90
Total Assets
141.87
142.63
126.12
110.42
115.73
126.23
176.92
152.99
134.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
3.75
0.29
1.42
1.12
17.23
-7.62
-29.35
22.08
12.04
PBT
1.61
8.59
6.11
-9.32
-11.63
-0.95
-9.69
13.12
13.55
Adjustment
-1.94
1.87
2.03
11.49
9.17
2.08
7.15
9.14
6.69
Changes in Working Capital
6.33
-5.99
-6.70
-1.08
19.71
-8.70
-26.81
-0.17
-5.01
Cash after chg. in Working capital
6.00
4.47
1.44
1.09
17.25
-7.56
-29.35
22.08
15.24
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.25
-4.18
-0.02
0.03
-0.02
-0.06
0.00
0.00
-3.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-10.45
-13.98
-4.45
-1.53
-19.57
-31.20
41.02
-23.87
-20.42
Net Fixed Assets
-1.00
-1.67
-0.87
-0.66
-0.56
-2.00
96.84
-24.29
Net Investments
1.58
0.88
-4.21
-4.10
-20.40
68.35
-138.00
-0.71
Others
-11.03
-13.19
0.63
3.23
1.39
-97.55
82.18
1.13
Cash from Financing Activity
1.57
16.86
5.51
-0.04
0.11
-0.06
-9.49
7.33
7.31
Net Cash Inflow / Outflow
-5.14
3.17
2.48
-0.45
-2.23
-38.87
2.18
5.54
-1.07
Opening Cash & Equivalents
7.94
4.77
2.29
2.75
4.98
43.85
9.49
3.95
5.03
Closing Cash & Equivalent
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
3.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
75.85
78.11
78.86
75.44
81.07
89.54
85.53
62.30
55.09
ROA
0.59%
2.85%
4.36%
-7.86%
-9.25%
-0.19%
46.26%
7.29%
7.96%
ROE
0.71%
3.36%
4.95%
-8.59%
-9.91%
-0.25%
78.03%
13.52%
14.76%
ROCE
1.95%
7.59%
6.08%
-8.69%
-10.11%
-0.74%
76.95%
13.06%
15.35%
Fixed Asset Turnover
0.76
1.20
0.76
0.44
0.48
0.88
2.33
2.05
2.01
Receivable days
120.72
88.79
125.86
197.00
252.10
265.25
88.74
106.38
122.60
Inventory Days
35.14
16.62
19.22
33.17
43.50
44.88
31.91
36.20
31.85
Payable days
42.27
32.14
59.43
52.58
37.09
69.84
26.25
31.47
35.31
Cash Conversion Cycle
113.59
73.27
85.65
177.59
258.51
240.30
94.40
111.12
119.14
Total Debt/Equity
0.11
0.08
0.01
0.01
0.00
0.00
0.08
0.64
0.59
Interest Cover
2.71
14.25
15.68
-58.98
-183.29
-17.71
33.88
4.71
3.99

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Kilitch Drugs’ arm gets manufacturing license to produce ‘Cephalosporin’
    19th Dec 2020, 10:45 AM

    The company has setup the state of art dedicated Cephalosporin facility and production of the same will commence soon

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.